GSK’s HIV drug wins European panel thumbs-up

Monday, 29 April 2019 00:00 - - {{hitsCtrl.values.hits}}

Reuters: GlaxoSmithKline PLC’s two-drug treatment for HIV infections won marketing approval from a European Medicines Agency (EMA) panel on Friday, after the British drug maker received a nod from the US Food and Drug Administration earlier this month.

EMA’s human medicines committee (CHMP) cleared the combination of dolutegravir and lamivudine, to be branded as Dovato, for treating newly-diagnosed adults, boosting GSK’s growth prospects against competitors.

Last year, the company showed in drug trials that the once-a-day Dovato pill was as good as a standard three-drug cocktail in suppressing the virus that causes AIDS and also in terms of tolerability.

While final approvals are up to the European Commission, it generally follows the CHMP’s recommendation and endorses them within a couple of months.

Discover Kapruka, the leading online shopping platform in Sri Lanka, where you can conveniently send Gifts and Flowers to your loved ones for any event including Valentine ’s Day. Explore a wide range of popular Shopping Categories on Kapruka, including Toys, Groceries, Electronics, Birthday Cakes, Fruits, Chocolates, Flower Bouquets, Clothing, Watches, Lingerie, Gift Sets and Jewellery. Also if you’re interested in selling with Kapruka, Partner Central by Kapruka is the best solution to start with. Moreover, through Kapruka Global Shop, you can also enjoy the convenience of purchasing products from renowned platforms like Amazon and eBay and have them delivered to Sri Lanka.